A Recent survey from Sanofi, of 200 UK adults living with aT1D reveals the unseen burden and challenges faced by people living with aT1D and on society at large[1]. Nearly all individuals (98%) reported that aT1D affects their physical health, 91% saying that it has taken a toll on their mental health[1]. The condition also affects personal relationships, as a third of individuals have had to explain it to close family members. Additionally, more than a quarter (26%) believe aT1D is more misunderstood than Type 2 Diabetes.[1]
Also featured is Duke Al Durham, a UK spoken word poet and hip-hop artist also living with aT1D. Together with Duke, the band have contributed their own lived experiences to the song's lyrics creating a meaningful anthem for those living with aT1D. The song has been released on Spotify under the name 1Type and is accompanied by a music video. Sanofi will donate an amount matching the profits from song to charities that support people living with aT1D.
aT1D is an autoimmune, complex, and lifelong condition – and it can happen at any age even without family history.[2] It can be a challenging disease with lifelong clinical, economic, and emotional unmet needs for patients and families. In the UK, there is a growing prevalence where approximately 400,000 people are living with the disease, including about 32,000 people 19 years of age and younger.[3],[4] It is known that aT1D is not caused by diet or lifestyle and the causes of aT1D are currently not fully understood. Researchers are exploring the genes and environmental triggers to understand if they play a part in causing the body's immune system to malfunction and start attacking the insulin-producing beta cells in the pancreas. In the UK, aT1D is managed through insulin therapy and glucose monitoring.[5]
Research has expanded our understanding of the underlying autoimmune mechanisms of aT1D and has now enabled earlier detection of the disease before symptoms appear.[6] Early detection is not currently available on the NHS. Early detection/early identification of individuals at risk for symptomatic Stage 3 autoimmune T1D may prevent traumatic Diabetic Ketoacidosis (DKA) through glucose monitoring and allow a softer and safer transition to life with aT1D as they learn about management at their own pace[7],[8]. Two large scale studies are underway in the UK that test eligible people[9]. You can learn more about early detection through ELSA study and T1DRA study.
1Type Band & Stagecoach students
Ella, Lola-Belle, Olivia & Finely
"Creating this song was a powerful experience. Sharing our stories through music has been more than we could have hoped for. We hope this song starts a conversation about type 1 diabetes and fosters a sense of community for others living with it."
Ahmed Moussa
General Manager, General Medicines UK and Ireland, Sanofi
"Supporting the aT1D community is a huge priority for us at Sanofi and this project has been very close to our hearts. These incredible kids are true rockstars, both on stage and, more importantly, in how they manage type 1 diabetes every single day. We are proud to stand alongside them, amplifying their voices."
Lisa Stead
Chief Operating Officer, Stagecoach Performing Arts
"We are incredibly proud to partner with Sanofi on this unique project. We believe in the transformative power of the arts. This project beautifully demonstrates how music can be a powerful tool for raising awareness and building empathy. It's been a fantastic opportunity for these talented young musicians to connect deeply over their shared experiences with aT1D and create something they will cherish forever."
About 1Type:
1Type is a newly formed girl band comprised of four talented teenage girls living with Type 1 diabetes: Ella, Lola-Belle, Finley, and Olivia. Hailing from across the UK and brought together through Stagecoach Performing Arts, with sponsorship from Sanofi, they are united by their shared experiences and on a mission to raise awareness of the condition and highlight the challenges faced by those living with it.
About Sanofi:
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
About Stagecoach:
Stagecoach Performing Arts was founded in 1988 and continues to grow as the UK's largest network of extra-curricular performing arts schools for children, with 60,000 students enrolled in our weekly classes worldwide. One of the first extra-curricular children's performing arts schools in the country, we aim to inspire our students, making a difference in their lives by teaching Creative Courage for Life®. With over 300 franchisees and 3,000 schools and classes worldwide delivering 5,000 hours per week, Stagecoach has a global presence with schools in countries including Canada, Germany, Malta, Spain, Gibraltar, Australia, and Lithuania. Notable alumni are Emma Watson, Jamie Bell, Eleanor Tomlinson, Tuppence Middleton, Tom Fletcher, Dani Harmer, Josh Cuthbert, Danny Mac, and Charlotte Jaconelli. For more information visit the website www.stagecoach.co.uk.
Document Number: MAT-XU-2500476 (v1.0)
References:
[1]Sanofi UK (2025). Perceptions of living with Type 1 Diabetes for Adults in the UK. Data on file.
[2] Diabetes UK. What causes Type 1 Diabetes? Available at: https://www.diabetes.org.uk/diabetes-the-basics/types-of-diabetes/type-1/causes. [Accessed: March 2025]
[3] Sze M Ng and Astha Soni. (2023, August 25). Ten-year review of trends in children with type 1 diabetes in England and Wales. World Journal of Diabetes, 14(8), 1194–1201.
[4] National Institute for Health and Care Excellence. "Type 1 Diabetes in Children and Young People: Incidence and Prevalence." Clinical Knowledge Summaries, https://cks.nice.org.uk/topics/diabetes-type-1/background-information/incidence-prevalence/. [Accessed: March 2025]
[5] Mathew TK, Zubair M, Tadi P. Blood Glucose Monitoring. [Updated 2023 Apr 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
[6] Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964–1974. [Accessed: March 2025]
[7] Sims EK, et al. Screening for type 1 diabetes in the general population: A Status Report and Perspective. Diabetes. 2022;71(4):610-623.
[8] Narendran P. Screening for type 1 diabetes: are we nearly there yet? Diabetologia. 2019;62(1):24-27.
[9] UK-first screening trial for type 1 diabetes sees 20,000 children sign up so far. (2024, June 25). Diabetes UK. https://www.diabetes.org.uk/about-us/news-and-views/uk-first-screening-trial-type-1-diabetes-sees-18000-children-sign-so-far [Accessed: March 2025]
Video: https://youtu.be/g0X-EIVehRI
Video - https://www.youtube.com/watch?v=asIZ0bNLQLc
Photo - https://mma.prnewswire.com/media/2684035/1Type.jpg
Logo - https://mma.prnewswire.com/media/2684082/Sanofi_Logo.jpg
Share this article